6 Promising Biopharmas With Major Catalysts in 2018 Post author:Sam Post published:January 28, 2018 Post category:BioPharma A look at six biopharma companies that may have major stock catalysts this year. Source: BioSpace You Might Also Like Biogen Forges $278M MS Tie-Up With Alkermes November 26, 2017 Amgen CEO Tells the Company Plans to Hire 1,600 Employees This Year January 31, 2017 Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics June 19, 2017
Kibow Biotech, Inc. (Buzz Of Bio Winner, 2014) Receives US Patent For Gout/Hyperuricemia Product Formulation Based On Modulation Of The Gut Microbiome With Probiotics And Prebiotics June 19, 2017
